Correlation Between Crinetics Pharmaceuticals and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Assembly Biosciences, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Assembly Biosciences.

Diversification Opportunities for Crinetics Pharmaceuticals and Assembly Biosciences

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Crinetics and Assembly is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Assembly Biosciences

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.69 times more return on investment than Assembly Biosciences. However, Crinetics Pharmaceuticals is 1.45 times less risky than Assembly Biosciences. It trades about 0.07 of its potential returns per unit of risk. Assembly Biosciences is currently generating about 0.03 per unit of risk. If you would invest  4,344  in Crinetics Pharmaceuticals on September 18, 2024 and sell it today you would earn a total of  1,193  from holding Crinetics Pharmaceuticals or generate 27.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Assembly Biosciences

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Assembly Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Crinetics Pharmaceuticals and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Assembly Biosciences

The main advantage of trading using opposite Crinetics Pharmaceuticals and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Crinetics Pharmaceuticals and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios